Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis ; volume:11 ; number:1 ; day:10 ; month:12 ; year:2018 ; pages:1-4 ; date:12.2018
BMC Research Notes / Biomed Central; 11, Heft 1 (10.12.2018), 1-4, 12.2018
- Creator
-
Vilela, Verônica Silva
Silva, Bruno Rangel Antunes da
Costa, Cláudia Henrique da
Lopes, Agnaldo José
Levy, Roger Abramino
Rufino, Rogério
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-018-3994-1
- URN
-
urn:nbn:de:101:1-2019012723551841123204
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vilela, Verônica Silva
- Silva, Bruno Rangel Antunes da
- Costa, Cláudia Henrique da
- Lopes, Agnaldo José
- Levy, Roger Abramino
- Rufino, Rogério
- SpringerLink (Online service)
Other Objects (12)
Impaired skeletal muscle microcirculation in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Physical activity in patients with systemic sclerosis
Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab
Glomerulonephritis associated with systemic sclerosis: a case report
Serum defensin levels in patients with systemic sclerosis
Impaired skeletal muscle microcirculation in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Physical activity in patients with systemic sclerosis
Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab
Glomerulonephritis associated with systemic sclerosis: a case report
Serum defensin levels in patients with systemic sclerosis
Impaired skeletal muscle microcirculation in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Physical activity in patients with systemic sclerosis
Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab
Glomerulonephritis associated with systemic sclerosis: a case report